Evidence map›Paper›PMID 12446773›Full record

ArticleMolecular and cellular biology2002

Early B-cell factor, E2A, and Pax-5 cooperate to activate the early B cell-specific mb-1 promoter.

Mikael Sigvardsson, Dawn R Clark, Daniel Fitzsimmons, Michelle Doyle, Peter Akerblad, Thomas Breslin, Sven Bilke, Ronggui Li, Carmen Yeamans, Gongyi Zhang and 1 more

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular biology, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 107 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. EBF1 is continuously required for stabilizing local chromatin accessibility in pro-B cells.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  7. Article
  8. Article
  9. Review
  10. Expression of PAX-5 in B Cell Hodgkin and Non Hodgkin LymphomaAsian Pacific journal of cancer prevention : APJCP · 2018
    Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Mikael SigvardssonDepartment for Stem Cell Biology, Lund, Sweden.
Dawn R Clark
Daniel Fitzsimmons
Michelle Doyle
Peter Akerblad
Thomas Breslin
Sven Bilke
Ronggui Li
Carmen Yeamans
Gongyi Zhang
James Hagman
National Jewish Health · USLund University · SEUniversity of Colorado Denver · USUniversity of Colorado Health · US

Funding

THE REGULATION OF V ALPHA 7 EXPRESSING T CELLSP01AI022295 · NIAID · NATIONAL JEWISH HEALTH · PI REFAELI, YOSEF · 1985 to 2011
$11.7M
BASIC IMMUNE MECHANISMS &IMMUNOLOGY DISEASET32AI000048 · NIAID · NATIONAL JEWISH HEALTH · PI KAPPLER, JOHN W · 1985 to 2002
$930k
REGULATION OF B CELL DIFFERENTIATION IN VITROR01AI037574 · NIAID · NATIONAL JEWISH HEALTH · PI HAGMAN, JAMES R · 1997 to 2001
$547k
NIAID NIH HHS P01 AI022295NIAID NIH HHS P01 AI22295NIAID NIH HHS R01 AI37574NIAID NIH HHS T32 AI000048NIAID NIH HHS T32 AI00048
6 · The paper itself

Abstract

Previous studies have suggested that the early-B-cell-specific mb-1(Igalpha) promoter is regulated by EBF and Pax-5. Here, we used in vivo footprinting assays to detect occupation of binding sites in endogenous mb-1 promoters at various stages of B-cell differentiation. In addition to EBF and Pax-5 binding sites, we detected occupancy of a consensus binding site for E2A proteins (E box) in pre-B cells. EBF and E box sites are crucial for promoter function in transfected pre-B cells, and EBF and E2A proteins synergistically activated the promoter in transfected HeLa cells. Other data suggest that EBF and E box sites are less important for promoter function at later stages of differentiation, whereas binding sites for Pax-5 (and its Ets ternary complex partners) are required for promoter function in all mb-1-expressing cells. Using DNA microarrays, we found that expression of endogenous mb-1 transcripts correlates most closely with EBF expression and negatively with Id1, an inhibitor of E2A protein function, further linking regulation of the mb-1 gene with EBF and E2A. Together, our studies demonstrate the complexity of factors regulating tissue-specific transcription and support the concept that EBF, E2A, and Pax-5 cooperate to activate target genes in early B-cell development.

Indexed as

Promoter Regions, GeneticAnimalsAntigens, CDBase SequenceBasic Helix-Loop-Helix ProteinsBinding SitesB-LymphocytesCD79 AntigensCell LineDNA-Binding ProteinsDNA FootprintingGene Expression RegulationGenes, ReporterHelix-Loop-Helix MotifsHumansMacromolecular SubstancesAntigens, CDBasic Helix-Loop-Helix ProteinsCD79 AntigensCD79A protein, humanCd79a protein, mouseDNA-Binding ProteinsEBF1 protein, humanEbf1 protein, mouseMacromolecular SubstancesNuclear ProteinsPAX5 protein, humanPax5 protein, mousePAX5 Transcription FactorReceptors, Antigen, B-CellRecombinant Fusion ProteinsTCF3 protein, humanTrans-ActivatorsTranscription Factors

Identifiers

PMID12446773
PMCPMC139876
OpenAlexW2115374084

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.